A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection

Jayashree Konar; Sanjeev Das; Abhra Banerjee

doi:10.5455/njppp.2022.12.09319202106092021

2024, Vol: 14, Issue: 10

14 / 10Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 21 Sep 2021

Natl J Physiol Pharm Pharmacol. 2022; 12(3): 322-324

doi: 10.5455/njppp.2022.12.09319202106092021

A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection

Jayashree Konar, Sanjeev Das, Abhra Banerjee.

Cited By:4

Abstract
Background: Urinary pathogens develop lesser resistance against Nitrofurantoin than other antimicrobials such as Fluoroquinolones, Cotrimoxazole, and Carbapenems.

Aim and Objective: The objective of this study was to estimate the sensitivity pattern of the urinary isolates against Nitrofurantoin in uncomplicated Urinary tract infection (UTI).

Materials and Methods: The descriptive cross-sectional study was performed from January 1, 2020, to June 30, 2020, with 759 cases with signs and symptoms of uncomplicated UTI. Aseptically collected midstream urine was inoculated on Nutrient Agar Media, MacConkeys Agar media, and Blood Agar media for bacterial isolation. Antimicrobial susceptibility testing was done by disk diffusion technique on Mueller Hinton Agar (Kirby Bauer technique) as per Clinical Laboratory Standards Institute guidelines.

Results: Out of total of 759 urine samples, in 165 cases bacterial pathogens were isolated (21.73%). Only 17 were resistant to Nitrofurantoin (10.30%) whereas resistance to Fluoroquinolone (Ciprofloxacin) was in 58 isolates (35.15%) and Cotrimoxazole, in 37 isolates (22.42%). Resistance against Carbapenem antibiotics (Imipenem and Meropenem) was found in 29 isolates (17.57%). All the Nitrofurantoin resistant isolates were Gram-negative. Majority of the Nitrofurantoin resistant isolates were Klebsiella pneumonia (8 out of 17, i.e, 47.05%). All Nitrofurantoin resistant isolates were sensitive to Colistin and Tigecycline. Five out of 17 Nitrofurantoin resistant isolates were sensitive to Meropenem and Imipenem (29.41%). The Fischer exact test reveals that Nitrofurantoin is effective against the isolates resistant to Fluoroquinolones, Cotrimoxazole, and Carbapenems.

Conclusion: Nitrofurantoin, even today, remains a good choice for empirical therapy for uncomplicated UTI.

Key words: Nitrofurantoin; Urinary Tract Infection; Empirical

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Jayashree Konar Articles by Sanjeev Das Articles by Abhra Banerjee
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Konar J, Das S, Banerjee A. A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection. Natl J Physiol Pharm Pharmacol. 2022; 12(3): 322-324. doi:10.5455/njppp.2022.12.09319202106092021

Web Style

Konar J, Das S, Banerjee A. A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection. https://www.njppp.com/?mno=118468 [Access: November 01, 2024]. doi:10.5455/njppp.2022.12.09319202106092021

AMA (American Medical Association) Style

Konar J, Das S, Banerjee A. A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection. Natl J Physiol Pharm Pharmacol. 2022; 12(3): 322-324. doi:10.5455/njppp.2022.12.09319202106092021

Vancouver/ICMJE Style

Konar J, Das S, Banerjee A. A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection. Natl J Physiol Pharm Pharmacol. (2022), [cited November 01, 2024]; 12(3): 322-324. doi:10.5455/njppp.2022.12.09319202106092021

Harvard Style

Konar, J., Das, . S. & Banerjee, . A. (2022) A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection. Natl J Physiol Pharm Pharmacol, 12 (3), 322-324. doi:10.5455/njppp.2022.12.09319202106092021

Turabian Style

Konar, Jayashree, Sanjeev Das, and Abhra Banerjee. 2022. A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection. National Journal of Physiology, Pharmacy and Pharmacology, 12 (3), 322-324. doi:10.5455/njppp.2022.12.09319202106092021

Chicago Style

Konar, Jayashree, Sanjeev Das, and Abhra Banerjee. "A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 322-324. doi:10.5455/njppp.2022.12.09319202106092021

MLA (The Modern Language Association) Style

Konar, Jayashree, Sanjeev Das, and Abhra Banerjee. "A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection." National Journal of Physiology, Pharmacy and Pharmacology 12.3 (2022), 322-324. Print. doi:10.5455/njppp.2022.12.09319202106092021

APA (American Psychological Association) Style

Konar, J., Das, . S. & Banerjee, . A. (2022) A hospital-based descriptive cross-sectional study in Eastern India to estimate the effect of nitrofurantoin, an age-old therapeutic option, in uncomplicated urinary tract infection. National Journal of Physiology, Pharmacy and Pharmacology, 12 (3), 322-324. doi:10.5455/njppp.2022.12.09319202106092021

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article